Literature DB >> 14583793

Multiple mechanisms of estrogen receptor gene repression contribute to ER-negative breast cancer.

F F Parl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14583793     DOI： 10.1038/sj.tpj.6500201

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  9 in total

1.  Loss of estrogen receptor 1 enhances cervical cancer invasion.

Authors:  Yali Zhai; Guido T Bommer; Ying Feng; Alexandra B Wiese; Eric R Fearon; Kathleen R Cho
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

2.  The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression.

Authors:  Ricardo López-Romero; Efraín Garrido-Guerrero; Angélica Rangel-López; Leticia Manuel-Apolinar; Patricia Piña-Sánchez; Minerva Lazos-Ochoa; Alejandra Mantilla-Morales; Cindy Bandala; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

3.  Physiological stress induces the metastasis marker AGR2 in breast cancer cells.

Authors:  Daniel R Zweitzig; Denis A Smirnov; Mark C Connelly; Leon W M M Terstappen; S Mark O'Hara; Elizabeth Moran
Journal:  Mol Cell Biochem       Date:  2007-08-11       Impact factor: 3.396

Review 4.  Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics.

Authors:  Natalia A Riobo-Del Galdo; Ángela Lara Montero; Eva V Wertheimer
Journal:  Cells       Date:  2019-04-25       Impact factor: 6.600

Review 5.  Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.

Authors:  Rocío García-Becerra; Nancy Santos; Lorenza Díaz; Javier Camacho
Journal:  Int J Mol Sci       Date:  2012-12-20       Impact factor: 5.923

6.  Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer.

Authors:  Julia M W Gee; Martin G Giles; Robert I Nicholson
Journal:  Breast Cancer Res       Date:  2004-06-09       Impact factor: 6.466

Review 7.  Tamoxifen Resistance: Emerging Molecular Targets.

Authors:  Milena Rondón-Lagos; Victoria E Villegas; Nelson Rangel; Magda Carolina Sánchez; Peter G Zaphiropoulos
Journal:  Int J Mol Sci       Date:  2016-08-19       Impact factor: 5.923

Review 8.  Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.

Authors:  Yunus A Luqmani; Nada Alam-Eldin
Journal:  Med Princ Pract       Date:  2016-02-05       Impact factor: 1.927

9.  Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells.

Authors:  Yumei Diao; Ani Azatyan; Mohammed Ferdous-Ur Rahman; Chunyan Zhao; Jian Zhu; Karin Dahlman-Wright; Peter G Zaphiropoulos
Journal:  Oncotarget       Date:  2016-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.